05/20/2025 | Press release | Distributed by Public on 05/20/2025 13:17
FORM C |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL |
|
OMB Number: ####-#### Estimated average burden hours per response: ##.# |
Filer CIK: |
0001139685
|
Filer CCC: |
XXXXXXXX
|
Period: |
01-31-2025
|
Is this a LIVE or TEST Filing? | LIVE TEST |
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? | |
Would you like a Return Copy? |
Name: |
|
Phone Number: |
|
Contact E-Mail Address: |
|
Notify via Filing Website only? |
Name of Issuer: |
20/20 Biolabs, Inc.
|
Form: |
Corporation
|
Jurisdiction of Incorporation/Organization: |
DELAWARE
|
Date of Incorporation/Organization: |
05-01-2000
|
Address 1: |
15810 GAITHER ROAD, SUITE 235
|
Address 2: |
SUITE 235
|
City: |
GAITHERSBURG
|
State/Country: |
MARYLAND
|
Mailing Zip/Postal Code: |
20877
|
Website of Issuer: |
https://2020biolabs.com/
|
Current Number of Employees: |
20.00
|
Total Assets Most Recent Fiscal Year-end: |
3584408.00
|
Total Assets Prior Fiscal Year-end: |
6367828.00
|
Cash and Cash Equivalents Most Recent Fiscal Year-end: |
1784009.00
|
Cash and Cash Equivalents Prior Fiscal Year-end: |
4089461.00
|
Accounts Receivable Most Recent Fiscal Year-end: |
135272.00
|
Accounts Receivable Prior Fiscal Year-end: |
68834.00
|
Short-term Debt Most Recent Fiscal Year-end: |
1355078.00
|
Short-term Debt Prior Fiscal Year-end: |
1011623.00
|
Long-term Debt Most Recent Fiscal Year-end: |
723848.00
|
Long-term Debt Prior Fiscal Year-end: |
1068713.00
|
Revenue/Sales Most Recent Fiscal Year-end: |
1752343.00
|
Revenue/Sales Prior Fiscal Year-end: |
1424304.00
|
Cost of Goods Sold Most Recent Fiscal Year-end: |
1373432.00
|
Cost of Goods Sold Prior Fiscal Year-end: |
1315166.00
|
Taxes Paid Most Recent Fiscal Year-end: |
0.00
|
Taxes Paid Prior Fiscal Year-end: |
0.00
|
Net Income Most Recent Fiscal Year-end: |
-5126667.00
|
Net Income Prior Fiscal Year-end: |
-6391309.00
|
Issuer: |
20/20 Biolabs, Inc.
|
Signature: |
Jonathan Cohen
|
Title: |
CEO
|
Signature: |
Jonathan Cohen
|
Title: |
CEO
|
Date: |
05-20-2025
|
Signature: |
Jiming Zhou
|
Title: |
COO
|
Date: |
05-20-2025
|
Signature: |
Ronald R Baker
|
Title: |
Chief Business Officer
|
Date: |
05-20-2025
|
Signature: |
John W Rollins
|
Title: |
Director
|
Date: |
05-20-2025
|
Signature: |
Richard M Cohen
|
Title: |
Director
|
Date: |
05-20-2025
|
Signature: |
Michael S. Lebowitz
|
Title: |
Chief Scientific Officer
|
Date: |
05-20-2025
|
Signature: |
John G. Compton
|
Title: |
Chair, Board of Directors
|
Date: |
05-20-2025
|
Signature: |
Michael A. Ross
|
Title: |
Director
|
Date: |
05-20-2025
|
Signature: |
Prasanth Reddy
|
Title: |
Director
|
Date: |
05-20-2025
|
Signature: |
Wei Lu
|
Title: |
Director on behalf of Ping An Ventures
|
Date: |
05-20-2025
|